Hurler syndrome. Case report
Keywords:
mucopolysaccharidosis I, Hurler syndrome, alpha-L-iduronidaseAbstract
Introduction: Hurler syndrome belongs to a group of diseases called muco polysaccharidosis and is a rare disease in pediatric age.Patient information: 12-year-old male adolescent, product of normal delivery, who at the age of two years started with loss of speech and constant drooling. He was evaluated by the Genetics Specialist who, due to his phenotypic characteristics, suspected a possible Hurler syndrome. We present an interesting case, not commonly seen in medical practice, with the aim of informing students and health professionals about the physical characteristics of the patient, who has survived more than 10 years of life.
Conclusions: the diagnosis was confirmed by mucopolysaccharide chromatography study performed at the National Genetics Center. Patients often die in the first decade of life due to respiratory and cardiac complications, hematopoietic precursor transplantation and enzyme therapy with alpha-L-iduronidase can improve life expectancy.
Downloads
References
1.Sardón O, García Pardos C, Mintegui J, Pérez Ruiz E, Coll MJ, Chabás A, et al. Evolución de dos pacientes con síndrome de Hurler en tratamiento con enzima recombinante humana α-L-iduronidasa. An Pediatr [Internet]. 2005 [citado 01/12/2019];63(1):61-67. Disponible en: https://analesdepediatria.org/es-evolucion-dos-pacientes-con-sindrome-articulo-resumen-13076769. https://doi.org/10.1157/13076769
2.Universidad Francisco Marroquín. Facultad de Medicina. Síndrome de Hurler [Internet]. Guatemala: Universidad Francisco Marroquín; 2016 [citado 01/12/2019]. Disponible en: https://medicina.ufm.edu/eponimo/sindrome-de-hurler/
3.Orphanet. Portal de información de enfermedades raras y medicamentos huérfanos [Internet]. París: Orphanet; 2019 [actualizado 30/03/2014; citado 01/12/2019]. Síndrome de Hurler [aprox. 4 pantallas]. Disponible en: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=ES&Expert=93473
4.Martínez Yero Y, Echavarría Estenoz DM. Un niño extraordinario fallecido a causa del síndrome de Hurler-Scheie. MEDISAN [Internet]. 2016 [citado 01/12/2019];20(3):408-417. Disponible en: https://www.redalyc.org/articulo.oa?id=368445188019
5.Monroy Garzón N, Rosas Martínez FA, Uribe Díaz S, Pedroza Vargas JA, Saavedra Bernal A, Uribe Ardila A. Mucopolisacaridosis tipo I: Síndrome de Hurler. Semilleros Med [Internet]. 2015 [citado 01/12/2019];9(1):18-23. Disponible en: https://www.umng.edu.co/documents/20127/432008/Semilleros+VOL9+2015.pdf/9d6c90fe-a377-9f11-fb14-d705757bb3b6?t=1573842665780
6.Toirac Cabrera X, Corvea Hernández L. Mucopolisacaridosis (síndrome de Hunter). Rev Cub Med Mil [Internet]. 2016 [citado 01/12/2019];45(1):79-84. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572016000100009&lng=es
7.Izquierdo Martínez M, Avellaneda Fernández A. Enfermedades raras, un enfoque práctico [Internet]. Madrid: Instituto de Salud Carlos III. Instituto de Investigación de Enfermedades Raras; 2004 [citado 03/01/2020]. Disponible en: http://gesdoc.isciii.es/gesdoccontroller?action=download&id=19/10/2012-ef90883d23
8.Pineda-Galindo LF, Moranchel-García L. Síndrome de Hurler-Scheie: mucopolisacaridosis tipo I. Med Int Méx [Internet]. 2015 [citado 01/12/2019];31:99-105. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2015/mim151n.pdf
9.Suarez-Guerrero JL, Gómez Higuera PJI, Arias Flórez JS, Contreras-García A. Mucopolisacaridosis: características clínicas, diagnóstico y de manejo. Rev Chil Pediatr [Internet]. 2016 [citado 01/12/2019];87(4):295-304. Disponible en: https://www.elsevier.es/es-revista-revista-chilena-pediatria-219-articulo-mucopolisacaridosis-caracteristicas-clinicas-diagnostico-manejo-S0370410615002582. https://doi.org/10.1016/j.rchipe.2015.10.004
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).